For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

The research, published in the European Heart Journal, revealed that cold weather may increase the susceptibility to ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo r ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

New research has shown that acute anaemia is associated with a 25% higher risk of a composite outcome of 30-day death or ...

Ann Robinson reviews the latest research Postpartum haemorrhage kills around 70 000 women a year. Since the results of the WOMAN trial in 2017, intravenous tranexamic acid given within three hours of ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

In the ABYSS trial, researchers found that interrupting a beta-blocker in patients after a myocardial infarction resulted in ...

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Common heart medications, like beta blockers, could have side effects including triggering depression in heart attack ...